Case study: First implantation of a frozen, devitalized tissueengineered vascular graft for urgent hemodialysis access

Journal of Vascular Access

Volumn 12, Issue 1, 2011, Pages 67-70

  Wystrychowski, Wojciech ^a   Cierpka, Lech ^a   Zagalski, Krzysztof ^a   Garrido, Sergio ^b   Dusserre, Nathalie ^c   Radochonski, Sam ^c   McAllister, Todd N ^c   L'Heureux, Nicolas ^c  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b FLENI   (Argentina)

^c Cytograft Tissue Engineering   (United States)

Author keywords

Autologous cell; ESRD (end stage renal disease); Graft devitalization; Hemodialysis; Vascular graft; Vascular tissue engineering

Indexed keywords

AGED; ARTERIOVENOUS FISTULA; ARTICLE; BLOOD VESSEL GRAFT; CASE REPORT; DIALYSIS CATHETER; ENDOTHELIUM CELL; FEMORAL VEIN; FIBROBLAST; HEMODIALYSIS; HUMAN; MALE; TISSUE ENGINEERING; VASCULAR ACCESS;

EID: 79953676333     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/JVA.2011.6360     Document Type: Article

References (13)

1. Huber TS, Carter JW, Carter RL, Seeger JM. Patency of autogenous and polytetrafluoroethylene upper extremity arteriovenous hemodialysis accesses: a systematic review. J Vasc Surg 2003; 38: 1005-11.
2. Gibson KD, Gillen DL, Caps MT, Kohler TR, Sherrard DJ, Stehman-Breen CO. Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg 2001; 34: 694-700.
3. Moss AH, Vasilakis C, Holley JL, Foulks CJ, Pillai K, McDowell DE. Use of a silicone dual-lumen catheter with a Dacron cuff as a long-term vascular access for hemodialysis patients. Am J Kidney Dis 1990; 16: 211-5.
4. Duszak R Jr, Haskal ZJ, Thomas-Hawkins C, et al. Replacement of failing tunneled hemodialysis catheters through pre-existing subcutaneous tunnels: a comparison of catheter function and infection rates for de novo placements and over-the-wire exchanges. J Vasc Interv Radiol 1998; 9: 321-7.
5. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: incidence, risk factors, and prognosis. Kidney Int 1999; 55: 1081-90.
6. Konig G, McAllister TN, Dusserre N, et al. Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenousvein and mammary artery. Biomaterials 2009; 30: 1542-50. Epub 2008 Dec 25.
7. Maya ID, Allon M. Outcomes of tunneled femoral hemodialysis catheters: comparison with internal jugular vein catheters. Kidney Int 2005; 68: 2886-9.
8. McAllister TN, Maruszewski M, Garrido SA, et al. Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study. Lancet 2009; 373: 1440-6.
9. L'Heureux N, McAllister TN, de la Fuente LM. Tissueengineered blood vessel for adult arterial revascularization. N Engl J Med 2007; 357: 1451-3.
10. Tominaga T, Kitagawa T, Masuda Y, et al. Viability of cryopreserved semilunar valves: an evaluation of cytosolic and mitochondrial activities. Ann Thorac Surg 2000; 70: 792-5.
11. Langerak SE, Groenink M, van der Wall EE, et al. Impact of current cryopreservation procedures on mechanical and functional properties of human aortic homografts. Transpl Int 2001; 14: 248-55.
12. Bia D, Pessana F, Armentano R, Pérez H, et al. Cryopreservation procedure does not modify human carotid homografts mechanical properties: an isobaric and dynamic analysis. Cell Tissue Bank 2006; 7: 183-94.
13. Pukacki F, Jankowski T, Gabriel M, Oszkinis G, Krasinski Z, Zapalski S. The mechanical properties of fresh and cryopreserved arterial homografts. Eur J Vasc Endovasc Surg 2000; 20: 21-4.